NFKB1 and rheumatoid arthritis: Studies have shown that emodin can inhibit the secretion of IL-9 by inhibiting the phosphorylation of IKK and the NF-κB signaling pathway, thereby inhibiting the proliferation of osteoclasts and reducing bone destruction in RA [110].